Qomel Past Earnings Performance
Past criteria checks 3/6
Qomel has been growing earnings at an average annual rate of 105.8%, while the Healthcare industry saw earnings growing at 20.3% annually. Revenues have been growing at an average rate of 46.4% per year. Qomel's return on equity is 24.8%, and it has net margins of 19.5%.
Key information
105.8%
Earnings growth rate
101.5%
EPS growth rate
| Healthcare Industry Growth | 12.3% |
| Revenue growth rate | 46.4% |
| Return on equity | 24.8% |
| Net Margin | 19.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Qomel makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 120 | 23 | 14 | 0 |
| 31 Mar 24 | 113 | 20 | 13 | 0 |
| 31 Dec 23 | 105 | 18 | 12 | 0 |
| 30 Sep 23 | 94 | 14 | 11 | 0 |
| 30 Jun 23 | 82 | 11 | 10 | 0 |
| 31 Mar 23 | 80 | 12 | 10 | 0 |
| 31 Dec 22 | 78 | 13 | 11 | 0 |
| 31 Dec 21 | 61 | 6 | 9 | 0 |
Quality Earnings: 9600 has a high level of non-cash earnings.
Growing Profit Margin: 9600's current net profit margins (19.5%) are higher than last year (13.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 9600's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare 9600's past year earnings growth to its 5-year average.
Earnings vs Industry: 9600 earnings growth over the past year (105.8%) exceeded the Healthcare industry 15.7%.
Return on Equity
High ROE: 9600's Return on Equity (24.8%) is considered high.